MTOR and prostate cancer: We also demonstrated that RNASE4 activates AKT and S6 in prostate cancer, suggesting that the PI3K-AKT-mTOR signaling pathway, known to play an important role in several cancers45,46 including prostate cancer35, was involved in RNASE4-stimulated cell proliferation.